Why Sponsors Choose Third Opinion

  • Accelerated Clinical Trial Timelines
  • Maximized Patient Enrollment Per Site
  • Feasibility & Site Selection Insights

Many eligible patients are hidden in unstructured EHR data — pathology reports, biopsies, and clinical notes that structured queries can't reach. Third Opinion integrates directly with site EHR systems to match patients against challenging inclusion and exclusion criteria, with physician oversight at every step.

Sponsors use Third Opinion to activate sites in weeks, enroll more patients at every site, and get site feasibility and cohort insights from data that used to be out of reach.

How Third Opinion Accelerates Your Trial

Find Eligible Patients That Could Be Missed

Find Eligible Patients Faster

Turn Unstructured Data Into Trial Insights

  • Integrates with the EHR each site already uses, including Epic, Athena, and Veradigm
  • Physician oversight throughout, with no workflow interruption at the site
  • Bi-weekly reports on every site's progress, with no PHI

A Trial-Ready Urology Network

Map of Third Opinion's urology partner sites across the US

18

Urology Practices in Network

~8M

Urology Patients Covered

9

Urology Sponsor Trials Run Across the Network

4

Disease States — NMIBC · mCRPC · UTUC · UTI

From Introduction To Enrolled Patients

A proven onboarding path, used to maximize patient enrollment at active trial sites.

  1. Introduction & Discovery Call

    You introduce Third Opinion to the site, and a 30-minute call walks the site's team through onboarding.

  2. BAA & EHR App Activation

    The site and Third Opinion sign a mutual BAA and scope the minimum-necessary data elements, and the site activates the Third Opinion app in its EHR.

  3. Live at active sites

    Data Integration & Trial Configuration

    The site's unstructured data is AI-enabled, and your trial criteria are configured against its EHR database.

  4. Live at active sites

    Bi-Weekly Patient Reviews & Sponsor Reports

    Third Opinion reviews newly qualified, trial-ready patients with each site every two weeks, and reports each site's activity to you, with no PHI.

Let's accelerate your urology program